Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
about
Trends in adherence to recommended cancer screening: the US population and working cancer survivorsRisk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysisOptimal breast cancer screening strategies for older women: current perspectivesNeoplastic disease after liver transplantation: Focus on de novo neoplasmsScreening mammography in older women: a reviewApplying what we know to accelerate cancer preventionIndividualizing cancer screening in older adults: a narrative review and framework for future researchThe value of models in informing resource allocation in colorectal cancer screening: the case of The NetherlandsBreast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.Breast cancer screening: an evidence-based updateShould Never-Smokers at Increased Risk for Lung Cancer Be Screened?Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.Cancer risks associated with external radiation from diagnostic imaging proceduresCost of breast-related care in the year following false positive screening mammograms.Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.Cancer Models and Real-world Data: Better Together.Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening.Evaluating outcomes of community-based cancer education interventions: a 10-year review of studies.Against conventional wisdom: when the public, the media, and medical practice collide.Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.Introduction of organised mammography screening in Tyrol: results of a one-year pilot phaseComparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task ForceAbdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit?The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesPursuing optimal thresholds to recommend breast biopsy by quantifying the value of tomosynthesis.Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceAggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.The emergence of translational epidemiology: from scientific discovery to population health impact.Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease.Breast cancer incidence and overdiagnosis in Catalonia (Spain)Modeling the impact of population screening on breast cancer mortality in the United States.Breast cancer screening: controversy of impact.Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.Breast and cervical screening by race/ethnicity: comparative analyses before and during the Great RecessionLocal breast cancer spatial patterning: a tool for community health resource allocation to address local disparities in breast cancer mortality.Patient understanding of the revised USPSTF screening mammogram guidelines: need for development of patient decision aids.
P2860
Q23922316-AEE39B30-16F2-421A-AE9A-A0B528FAFB56Q24628928-0FEDC178-AEC8-4B0B-A266-41DD8BAB350CQ26764816-53E78175-8679-49FD-806B-1E05EA435B4CQ26798306-9D2730AE-CE9B-4E6B-BD87-6635585E3DB9Q26829839-0D4D73AA-18D2-43A5-8D63-4F14BBDDAB19Q26864696-0B01D013-0A6A-4F56-9C5A-49CA10A96F9CQ26997738-0A35DBD3-1DB4-41FC-B2B5-490D93D5D113Q27015647-DFA4BD1E-229F-4823-954A-BE558E32AFB6Q27347760-3F78A93A-DD7E-41D5-ACF0-82B82F5DCC3AQ28081267-8C8F19FA-E1AA-445E-9DFC-4DC9914E1808Q28386729-47E7B6A7-DBAA-46B3-A60D-7B78862CD695Q28388251-77205C3D-39F8-4147-BECA-DC371224072CQ28393308-43926BF2-7B26-4BE8-9C9D-9E6FECD4743CQ30499746-157EC3A9-F1E6-4AF0-A97B-99FB72143910Q30595581-C471DC47-3123-4AD2-8803-DEA3A8D606EAQ31018210-552E89B9-9577-4F78-8426-E1C698252402Q33532804-B40C9889-8193-4F0D-B439-3E26472D1733Q33574006-0BF0161A-A12A-45A9-8EED-35D7B8406DD5Q33645368-E303A782-FA0A-4D3A-91B3-5E328DDE742BQ33651094-F47F8D09-237B-4E25-BF87-E19DA10CB76BQ33792616-F21C4AB2-78D7-4790-9DD2-8D71E27A789AQ33816343-493E53F0-6778-480C-89BC-550040E08355Q33825806-DEC468DC-EC63-410E-B2BA-70295E7D2171Q33834430-7216586C-899D-4FC1-8ED6-4D77553FE204Q33859917-AF3480EF-CAD0-4C25-919B-24709CC59458Q33906120-E56FD514-5106-416D-ABC0-80D71DC8A29DQ33917618-E623490B-ADA4-493B-ACF6-1956A75695BBQ33958483-AF03BF67-C5B9-4662-B297-86AC5F370090Q33978331-E5530D70-C3BA-42A6-93B3-8BA9D77B306FQ34079901-CF9D038F-28CF-4C31-9442-C6E1927170B8Q34082166-3F891F92-5C22-46BE-AE50-48D1AEC96625Q34159375-40FB61C0-8A79-43B4-AE95-5A0265B54E74Q34171768-397613FB-16CD-49F6-8835-25E8B0EDA707Q34173521-9B616EB2-6052-41FD-82D3-D349842B567EQ34225972-50F2E99F-3B52-4885-A0A7-B97089DEA92AQ34318322-17B9493F-1E83-442A-82C0-7CEF6BB3C052Q34326169-D2FC36C2-5098-4AE9-B70B-F4D49F61AAFEQ34378374-5B7B4A00-004B-4015-9FE2-793529496DEFQ34428438-775C70DB-9450-486B-9BEE-7E2B4ABCB35BQ34439196-6F998903-D524-4FDC-A8D3-42885E849F04
P2860
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effects of mammography screeni ...... potential benefits and harms.
@ast
Effects of mammography screeni ...... potential benefits and harms.
@en
type
label
Effects of mammography screeni ...... potential benefits and harms.
@ast
Effects of mammography screeni ...... potential benefits and harms.
@en
prefLabel
Effects of mammography screeni ...... potential benefits and harms.
@ast
Effects of mammography screeni ...... potential benefits and harms.
@en
P2093
P2860
P1476
Effects of mammography screeni ...... potential benefits and harms.
@en
P2093
Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network
Bronislava Sigal
Clyde B Schechter
Donald A Berry
Eric J Feuer
Gerrit Draisma
Harry J de Koning
Jeanne S Mandelblatt
John Venier
P2860
P304
P356
10.7326/0003-4819-151-10-200911170-00010
P407
P577
2009-11-01T00:00:00Z